ATAI
part sad study completed august healthy adult participants cohort cohort cohort cohort cohort fed cohort in addition to safety including respiratory and assessments evoked pain tests were administered to all cohorts part comparator study results by healthy male participants single oral dose single oral dose single oral dose single oral dose single oral dose single oral dose matching placebo matching placebo matching placebo day single dose day washout day single dose day washout day single dose this phase is designed unlock the therapeutic potential improved profile of | ATAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
39 of 41
Related slides by other companies
GH Research
Investor Presentation
May 2023
phase single dose efficacy | GH Research
GH Research
Investor Presentation
March 2023
phase single dose efficacy | GH Research
GH Research
Investor Presentation
May 2023
and observed improved outcome in phase phase single dose | GH Research
GH Research
Investor Presentation
March 2023
and observed improved outcome in phase phase single dose | GH Research
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io